Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,13 USD | -4,05% | -23,93% | +66,41% |
Vakgebied
Aantal werknemers: 30
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04-01-16 |
Preston Klassen
PSD | President | 55 | 22-06-23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30-08-19 |
Chief Tech/Sci/R&D Officer | - | 29-11-22 | |
Rekha Garg
LAW | General Counsel | - | 29-11-22 |
Amin Kamel
PRN | Corporate Officer/Principal | - | 02-06-22 |
Daniel Penksa
AUD | Comptroller/Controller/Auditor | 39 | 01-06-15 |
Christopher Aker
LAW | General Counsel | 63 | 19-05-11 |
Brian K. Campion
PRN | Corporate Officer/Principal | - | 01-07-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01-06-17 |
David Baltimore
BRD | Director/Board Member | 86 | 01-01-09 |
Director/Board Member | 75 | 01-04-13 | |
Chairman | 74 | 01-01-08 | |
Jake Nunn
BRD | Director/Board Member | 54 | 11-06-19 |
Alice S. Huang
BRD | Director/Board Member | 85 | 26-01-21 |
Hugh Rosen
BRD | Director/Board Member | 64 | 02-06-16 |
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04-01-16 |
Preston Klassen
PSD | President | 55 | 22-06-23 |
Director/Board Member | 56 | 17-04-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 3 725 720 | 0 | 0 | 96,25 % |
Aandeel B | 0 | 258 707 | 0 | 0 | |
Aandeel C | 0 | 1 330 832 | 0 | 0 | |
Aandeel D | 1 | 65 465 251 | 64 540 836 ( 98,59 %) | 0 | |
Aandeel E | 0 | 256 700 | 0 | 0 |
Bedrijfsgegevens
Regulus Therapeutics, Inc.
4224 Campus Point Court Suite 210
92121, San Diego
+858 202 6300
http://www.regulusrx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+73,44% | 145 mln. | |
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-0,79% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-7,66% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |
- Beurs
- Aandelen
- Koers RGLS
- Onderneming Regulus Therapeutics Inc.